MAPT and Alzheimer disease: In the AD brain, both the transcript and the protein levels of I2PP2A are increased (Tanimukai et al., 2005), and the I2PP2A protein is co-localized with PP2A and the abnormally hyperphosphorylated tau in the neuronal cytoplasm (Tanimukai et al., 2005).